Click for best price
NK Cell Therapy Market Size, Share 2023
| Market size in 2022 |
US$ 357.9 million
|
Forecast Market size by 2029 |
US$ 981.5 million
|
| Growth Rate |
CAGR of 15.5% |
Number of Pages |
62 Pages |
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
This report aims to provide a comprehensive presentation of the global market for NK Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NK Cell Therapy. This report contains market size and forecasts of NK Cell Therapy in global, including the following market information:
Global NK Cell Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global NK Cell Therapy market was valued at US$ 357.9 million in 2022 and is projected to reach US$ 981.5 million by 2029, at a CAGR of 15.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest NK Cell Therapy market with about 51% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech etc. Top 3 companies occupied about 82% market share.
We surveyed the NK Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NK Cell Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global NK Cell Therapy Market Segment Percentages, by Type, 2022 (%)
NK Cell Therapies
NK Cell Directed Antibodies
Global NK Cell Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global NK Cell Therapy Market Segment Percentages, by Application, 2022 (%)
Cancer
Gastrointestinal Diseases
Others
Global NK Cell Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global NK Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies NK Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies NK Cell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of NK Cell Therapy, market overview.
Chapter 2: Global NK Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of NK Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of NK Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
NK Cell Therapy Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 357.9 million
|
| Forecast Market size by 2029 |
US$ 981.5 million
|
| Growth Rate |
CAGR of 15.5% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 NK Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NK Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NK Cell Therapy Overall Market Size
2.1 Global NK Cell Therapy Market Size: 2022 VS 2029
2.2 Global NK Cell Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top NK Cell Therapy Players in Global Market
3.2 Top Global NK Cell Therapy Companies Ranked by Revenue
3.3 Global NK Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 NK Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies NK Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 NK Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 NK Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 NK Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global NK Cell Therapy Market Size Markets, 2022 & 2029
4.1.2 NK Cell Therapies
4.1.3 NK Cell Directed Antibodies
4.2 By Type - Global NK Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global NK Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global NK Cell Therapy Revenue, 2024-2029
4.2.3 By Type - Global NK Cell Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global NK Cell Therapy Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Gastrointestinal Diseases
5.1.4 Others
5.2 By Application - Global NK Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global NK Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global NK Cell Therapy Revenue, 2024-2029
5.2.3 By Application - Global NK Cell Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global NK Cell Therapy Market Size, 2022 & 2029
6.2 By Region - Global NK Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global NK Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global NK Cell Therapy Revenue, 2024-2029
6.2.3 By Region - Global NK Cell Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America NK Cell Therapy Revenue, 2018-2029
6.3.2 US NK Cell Therapy Market Size, 2018-2029
6.3.3 Canada NK Cell Therapy Market Size, 2018-2029
6.3.4 Mexico NK Cell Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe NK Cell Therapy Revenue, 2018-2029
6.4.2 Germany NK Cell Therapy Market Size, 2018-2029
6.4.3 France NK Cell Therapy Market Size, 2018-2029
6.4.4 U.K. NK Cell Therapy Market Size, 2018-2029
6.4.5 Italy NK Cell Therapy Market Size, 2018-2029
6.4.6 Russia NK Cell Therapy Market Size, 2018-2029
6.4.7 Nordic Countries NK Cell Therapy Market Size, 2018-2029
6.4.8 Benelux NK Cell Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia NK Cell Therapy Revenue, 2018-2029
6.5.2 China NK Cell Therapy Market Size, 2018-2029
6.5.3 Japan NK Cell Therapy Market Size, 2018-2029
6.5.4 South Korea NK Cell Therapy Market Size, 2018-2029
6.5.5 Southeast Asia NK Cell Therapy Market Size, 2018-2029
6.5.6 India NK Cell Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America NK Cell Therapy Revenue, 2018-2029
6.6.2 Brazil NK Cell Therapy Market Size, 2018-2029
6.6.3 Argentina NK Cell Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa NK Cell Therapy Revenue, 2018-2029
6.7.2 Turkey NK Cell Therapy Market Size, 2018-2029
6.7.3 Israel NK Cell Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia NK Cell Therapy Market Size, 2018-2029
6.7.5 UAE NK Cell Therapy Market Size, 2018-2029
7 NK Cell Therapy Companies Profiles
7.1 Nektar Therapeutics
7.1.1 Nektar Therapeutics Company Summary
7.1.2 Nektar Therapeutics Business Overview
7.1.3 Nektar Therapeutics NK Cell Therapy Major Product Offerings
7.1.4 Nektar Therapeutics NK Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Nektar Therapeutics Key News & Latest Developments
7.2 Innate Pharma SA
7.2.1 Innate Pharma SA Company Summary
7.2.2 Innate Pharma SA Business Overview
7.2.3 Innate Pharma SA NK Cell Therapy Major Product Offerings
7.2.4 Innate Pharma SA NK Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Innate Pharma SA Key News & Latest Developments
7.3 Affimed
7.3.1 Affimed Company Summary
7.3.2 Affimed Business Overview
7.3.3 Affimed NK Cell Therapy Major Product Offerings
7.3.4 Affimed NK Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Affimed Key News & Latest Developments
7.4 Chipscreen Biosciences
7.4.1 Chipscreen Biosciences Company Summary
7.4.2 Chipscreen Biosciences Business Overview
7.4.3 Chipscreen Biosciences NK Cell Therapy Major Product Offerings
7.4.4 Chipscreen Biosciences NK Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 Chipscreen Biosciences Key News & Latest Developments
7.5 Fate Therapeutics
7.5.1 Fate Therapeutics Company Summary
7.5.2 Fate Therapeutics Business Overview
7.5.3 Fate Therapeutics NK Cell Therapy Major Product Offerings
7.5.4 Fate Therapeutics NK Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 Fate Therapeutics Key News & Latest Developments
7.6 Glycostem Therapeutics
7.6.1 Glycostem Therapeutics Company Summary
7.6.2 Glycostem Therapeutics Business Overview
7.6.3 Glycostem Therapeutics NK Cell Therapy Major Product Offerings
7.6.4 Glycostem Therapeutics NK Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Glycostem Therapeutics Key News & Latest Developments
7.7 Dragonfly Therapeutics
7.7.1 Dragonfly Therapeutics Company Summary
7.7.2 Dragonfly Therapeutics Business Overview
7.7.3 Dragonfly Therapeutics NK Cell Therapy Major Product Offerings
7.7.4 Dragonfly Therapeutics NK Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Dragonfly Therapeutics Key News & Latest Developments
7.8 Kiadis Pharma
7.8.1 Kiadis Pharma Company Summary
7.8.2 Kiadis Pharma Business Overview
7.8.3 Kiadis Pharma NK Cell Therapy Major Product Offerings
7.8.4 Kiadis Pharma NK Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Kiadis Pharma Key News & Latest Developments
7.9 NantWorks
7.9.1 NantWorks Company Summary
7.9.2 NantWorks Business Overview
7.9.3 NantWorks NK Cell Therapy Major Product Offerings
7.9.4 NantWorks NK Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 NantWorks Key News & Latest Developments
7.10 Nkarta Therapeutics
7.10.1 Nkarta Therapeutics Company Summary
7.10.2 Nkarta Therapeutics Business Overview
7.10.3 Nkarta Therapeutics NK Cell Therapy Major Product Offerings
7.10.4 Nkarta Therapeutics NK Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 Nkarta Therapeutics Key News & Latest Developments
7.11 Fortress Biotech
7.11.1 Fortress Biotech Company Summary
7.11.2 Fortress Biotech Business Overview
7.11.3 Fortress Biotech NK Cell Therapy Major Product Offerings
7.11.4 Fortress Biotech NK Cell Therapy Revenue in Global Market (2018-2023)
7.11.5 Fortress Biotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. NK Cell Therapy Market Opportunities & Trends in Global Market
Table 2. NK Cell Therapy Market Drivers in Global Market
Table 3. NK Cell Therapy Market Restraints in Global Market
Table 4. Key Players of NK Cell Therapy in Global Market
Table 5. Top NK Cell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global NK Cell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global NK Cell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies NK Cell Therapy Product Type
Table 9. List of Global Tier 1 NK Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 NK Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global NK Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - NK Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - NK Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global NK Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - NK Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - NK Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global NK Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global NK Cell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global NK Cell Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America NK Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America NK Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe NK Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe NK Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia NK Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia NK Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America NK Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America NK Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa NK Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa NK Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Nektar Therapeutics Company Summary
Table 31. Nektar Therapeutics NK Cell Therapy Product Offerings
Table 32. Nektar Therapeutics NK Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Nektar Therapeutics Key News & Latest Developments
Table 34. Innate Pharma SA Company Summary
Table 35. Innate Pharma SA NK Cell Therapy Product Offerings
Table 36. Innate Pharma SA NK Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Innate Pharma SA Key News & Latest Developments
Table 38. Affimed Company Summary
Table 39. Affimed NK Cell Therapy Product Offerings
Table 40. Affimed NK Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Affimed Key News & Latest Developments
Table 42. Chipscreen Biosciences Company Summary
Table 43. Chipscreen Biosciences NK Cell Therapy Product Offerings
Table 44. Chipscreen Biosciences NK Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Chipscreen Biosciences Key News & Latest Developments
Table 46. Fate Therapeutics Company Summary
Table 47. Fate Therapeutics NK Cell Therapy Product Offerings
Table 48. Fate Therapeutics NK Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Fate Therapeutics Key News & Latest Developments
Table 50. Glycostem Therapeutics Company Summary
Table 51. Glycostem Therapeutics NK Cell Therapy Product Offerings
Table 52. Glycostem Therapeutics NK Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Glycostem Therapeutics Key News & Latest Developments
Table 54. Dragonfly Therapeutics Company Summary
Table 55. Dragonfly Therapeutics NK Cell Therapy Product Offerings
Table 56. Dragonfly Therapeutics NK Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Dragonfly Therapeutics Key News & Latest Developments
Table 58. Kiadis Pharma Company Summary
Table 59. Kiadis Pharma NK Cell Therapy Product Offerings
Table 60. Kiadis Pharma NK Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Kiadis Pharma Key News & Latest Developments
Table 62. NantWorks Company Summary
Table 63. NantWorks NK Cell Therapy Product Offerings
Table 64. NantWorks NK Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. NantWorks Key News & Latest Developments
Table 66. Nkarta Therapeutics Company Summary
Table 67. Nkarta Therapeutics NK Cell Therapy Product Offerings
Table 68. Nkarta Therapeutics NK Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Nkarta Therapeutics Key News & Latest Developments
Table 70. Fortress Biotech Company Summary
Table 71. Fortress Biotech NK Cell Therapy Product Offerings
Table 72. Fortress Biotech NK Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Fortress Biotech Key News & Latest Developments
List of Figures
Figure 1. NK Cell Therapy Segment by Type in 2022
Figure 2. NK Cell Therapy Segment by Application in 2022
Figure 3. Global NK Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global NK Cell Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global NK Cell Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by NK Cell Therapy Revenue in 2022
Figure 8. By Type - Global NK Cell Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global NK Cell Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global NK Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global NK Cell Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global NK Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global NK Cell Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global NK Cell Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America NK Cell Therapy Revenue Market Share, 2018-2029
Figure 16. US NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe NK Cell Therapy Revenue Market Share, 2018-2029
Figure 20. Germany NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia NK Cell Therapy Revenue Market Share, 2018-2029
Figure 28. China NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America NK Cell Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa NK Cell Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE NK Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Nektar Therapeutics NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Innate Pharma SA NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Affimed NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Chipscreen Biosciences NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Fate Therapeutics NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Glycostem Therapeutics NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Dragonfly Therapeutics NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Kiadis Pharma NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. NantWorks NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Nkarta Therapeutics NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Fortress Biotech NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
